Pulmonary capillary hemangiomatosis: an unusual cause of primary pulmonary hypertension in pediatric age group
DOI:
https://doi.org/10.18203/2349-3291.ijcp20231861Keywords:
Pulmonary capillary hemangiomatosis, Pulmonary hypertension, Right-sided heart failureAbstract
Pulmonary capillary hemangiomatosis (PCH) is a rare and controversial entity that is known to be a cause of pulmonary hypertension and is microscopically characterized by proliferation of dilated capillary-sized channels along and in the alveolar walls. Clinically, it is mostly seen in adults. PCH’s main clinical presentations are progressive dyspnea, fatigue, hemoptysis, palpitations and later irreversible pulmonary hypertension and right-sided heart failure. It is characterized by severe hypoxemia, centrilobular ground-glass opacities on computed tomography and pulmonary congestion triggered by pulmonary vasodilating therapy. The imaging features include diffuse centrilobular ground‑glass opacities with features of pulmonary hypertension. We present a case of PCH in a 4‑year‑old boy who was diagnosed with post-partum hemorrhage (PPH) in echocardiography and computed tomography of the thorax.
References
Eltorky MA, Headley AS, Winer-Muram H, Garrett HE Jr, Griffin JP. Pulmonary capillary hemangiomatosis: a clinicopathologic review. Ann Thorac Surg. 1994;57(3):772-6.
Leslie KO, Wick MR. Pulmonary hypertension: practical pulmonary pathology: a diagnostic approach. 2nd ed. Philadelphia: Elsevier Saunders. Chapter 11. 2011;375-90.
Al-Fawaz IM, al Mobaireek KF, al-Suhaibani M, Ashour M. Pulmonary capillary hemangiomatosis: a case report and review of the literature. Pediatr Pulmonol. 1995;19(4):243-8.
Aston K, Riddell GJ, Sheppard MN, Wells AU, Riley MS. Pulmonary capillary haemangiomatosis – An unusual cause of hypoxia. Respir Med Case Rep. 2012;7:12‑4.
O’Keefe MC, Post MD. Pulmonary capillary hemangiomatosis: a rare cause of pulmonary hypertension. Arch Pathol Lab Med. 2015;139:274-7.
Wagenvoort C, Beetstra A, Spijker J. Capil¬lary haemangiomatosis of the lungs. Histo¬pathology. 1978;2:401-6.
Best DH, Sumner KL, Austin ED, Chung WK, Brown LM, Borczuk AC, et al. EIF2AK4 mu¬tations in pulmonary capillary hemangiomato¬sis. Chest. 2014;145:231-6.
Eyries M, Montani D, Girerd B, Perret C, Leroy A, Lonjou C, et al. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension. Nat Genet. 2014;46:65.
El-Gabaly M, Farver CF, Budev MA, Moham¬med TL. Pulmonary capillary hemangiomatosis imaging findings and literature update. J Com¬put Assist Tomogr. 2007;31:608-10.
Aluja Jaramillo F, Gutierrez FR, Díaz Telli FG, Yevenes Aravena S, Javidan-Nejad C, Bhal¬la S. Approach to pulmonary hypertension: from CT to clinical diagnosis. RadioGraphics. 2018;38:357-73.
